Vernon, John A.; Johnson, Scott J.; Hughen, W. Keener; … - In: PharmacoEconomics 24 (2006) 4, pp. 335-343
The pharmaceutical industry's core business is the innovation, development and marketing of new drugs. Pharmacogenetic (PG) testing and technology has the potential to increase a drug's value in many ways. A critical issue for the industry is whether products in development should be teamed with...